Zalevsky Jonathan sold 186 shares of NEKTAR THERAPEUTICS at $71.98 for −$13.4k on Aug 18, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief R&D Officer
Chief R&D Officer
Filed Aug 20, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$13,388.28Shares × reported price
Shares traded
186Common Stock
Price per share
$71.98Reported price. Read footnotes for ranges.
% of reported position traded
1.91%This security and ownership context
Holdings after
9,570Direct
Trade date
Aug 18, 2026Sell
Filed
Aug 20, 2026, 7:05 PM ET2-day reporting delay
Accession
0001193125-26-359588Code S · Transaction 15244
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 9,756 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

NKTR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NKTR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −8.4%1w ago +1.4%1d ago −2.4%
Returns since7d +0.1%30d −9.9%90d180d1y

Footnotes in full

F1: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person. F2: This transaction was executed in multiple trades at prices ranging from $71.78 to $72.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.